Last reviewed · How we verify
NCT03489330
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
trial in Infectious Disease in 2,000 participants. Completed in 29 December 2020.
1 October 2017
Quick facts
| Lead sponsor | Midwestern University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2014 |
| Primary completion | 1 October 2017 |
| Estimated completion | 29 December 2020 |
| Sites | 1 location across United States |
Conditions studied
- Infectious Disease — all drugs for Infectious Disease →
Sponsor
Midwestern University
Who can join
Adults 18 to 90, any sex, with Infectious Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In order to decrease inappropriate antibiotic use, drivers of inappropriate use must be identified locally. This study will focus on the MOST inappropriate use, which are defined as 'never events'. Previous work has shown that antibiotic use clusters over time. It is hypothesized that never events also cluster over time. Using electronic data capture strategies, an algorithm will be developed to quickly and accurately identify areas of antibiotic use concern. Secondly, a framework will be developed, utilizing antimicrobial consumption data and captured signals of inappropriate antimicrobial use to provide targets for antimicrobial stewardship efforts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03489330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infectious Disease
Currently open trials in the same condition.
- NCT06426147 — L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) · NA · recruiting
- NCT07069400 — An International Observational Study of Adults With Acute Infection · recruiting
- NCT06422338 — A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients) · NA · recruiting
- NCT06510699 — Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial · Phase 2 · recruiting
- NCT05972772 — Rickettsia Clearance Study · Phase 2, PHASE3 · recruiting
Other Midwestern University trials
Trials by the same sponsor.
- NCT06758310 — Exercise Effects in Native American Adolscents · NA · not yet recruiting
- NCT07203456 — Testing Educational Modalities for Temporomandibular Disorders Curriculum · NA · recruiting
- NCT05877560 — Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency · NA · recruiting
- NCT06730425 — Examining Stress Salivary Biomarkers in Pediatric Patients Undergoing Dental Procedures · completed
- NCT07209124 — Increasing Engagement and Positive Emotional Behavior of Older Adults With Mild-Moderate Dementia With the Use of Motion · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03489330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Midwestern University
- Last refreshed: 16 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03489330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing